Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

A currently-recruiting trial is comparing how two types of basal insulin – Toujeo and Tresiba – impact blood sugar levels in adults, using continuous glucose monitoring
The FDA finds that some versions of extended-release metformin contain excessive amounts of a cancer-causing chemical called NDMA
Comedian and actor Billy Gardell spoke with diaTribe about his journey with type 2 diabetes and how he has changed both his outlook and his habits
Qtrilmet is a once-daily pill that combines metformin, Farxiga, and Onglyza and helps lower A1C and support weight loss​. Already approved in US as “Qternmet”
Will the medication move from “off label” to standard of care for people at high risk of developing type 2 diabetes?
Mail-order pharmacies operate through your health insurance plan and can be cheaper and more convenient than getting your medications from a local pharmacy; learn about...
A few weeks ago, Kelly experienced severe hypoglycemia (she left her RileyLink in her basement by accident!) – lucky for her, she had just picked up a new emergency...
A prescription discount card can be used to reduce out-of-pocket costs of diabetes medications
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
By Becky Milner A company called Intarcia has developed a GLP-1 mini-pump that is implanted under the skin to continuously provide medication for six months at a time –...
The Medicine Assistance Tool (MAT) is a search engine to help find patient assistance resources for your medications
Farxiga becomes the first SGLT-2 inhibitor drug approved to reduce the risk of hospitalization for heart failure in adults who have type 2 diabetes and heart disease or...
The SGLT-2 inhibitor becomes the first diabetes medicine approved to treat kidney disease and reduce the risk of hospitalization for heart failure in people with type 2...
A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease
The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...
An oral (pill) version of Ozempic, Rybelsus, becomes the first GLP-1 agonist pill for type 2 diabetes
Read about the approval of Rybelsus, the first oral GLP-1 agonist, here . “I do think this is a great day for people with diabetes. I do hope that primary care providers...
The diaTribe team was in Barcelona for the 55 th Annual Meeting of the European Association for the Study of Diabetes. Check out our biggest highlights from the...
Beginning in 2020, nation-wide Cigna (and Express Scripts) and three Minnesota insurance companies (Blue Cross and Blue Shield, Medica, and UCare) will cap total monthly...
What is LADA? How is it diagnosed and treated? Read on to learn more and hear from people living with LADA

Pages